Levocetirizine Plus Bed-Time Hydroxyzine in the Management of Corticodependent Chronic Urticaria Versus Levocetirizine Alone in High Doses

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

March 31, 2013

Conditions
Chronic Urticaria
Interventions
DRUG

Levocetirizine

20 mg levocetirizine for 5 days

DRUG

Levocetirizine plus Hydroxyzine

24 patient will receive 15 mg Levocetirizine plus 50 mg Hydroxyzine at bad time for 5 days

Trial Locations (1)

1431

Medical University Sofia, Department of Allergology, Sofia

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

UCB Pharma

INDUSTRY

lead

Association Asthma, Bulgaria

OTHER